# Controlled Trial of Hydrogen Water as a Treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

> **NCT07753122** · NA · RECRUITING · sponsor: **Fred Friedberg** · enrollment: 80 (estimated)

## Conditions studied

- Chronic Fatigue Syndrome (CFS)

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo condition
- **DIETARY_SUPPLEMENT:** Molecular hydrogen produced by a metallic magnesium tablet, consumed 3x a day dissolved in water. Treatment duration is 16 weeks.

## Key facts

- **NCT ID:** NCT07753122
- **Lead sponsor:** Fred Friedberg
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-15
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07753122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07753122, "Controlled Trial of Hydrogen Water as a Treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07753122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*